Persistent Asset Partners Ltd Takes $1 Million Position in HCA Healthcare, Inc. $HCA

Persistent Asset Partners Ltd bought a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund bought 2,353 shares of the company’s stock, valued at approximately $1,003,000.

A number of other large investors also recently made changes to their positions in the business. Clearstead Trust LLC grew its position in HCA Healthcare by 311.8% during the second quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock valued at $27,000 after purchasing an additional 53 shares in the last quarter. Harbor Capital Advisors Inc. grew its holdings in shares of HCA Healthcare by 82.9% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock valued at $32,000 after acquiring an additional 34 shares in the last quarter. Twin Peaks Wealth Advisors LLC purchased a new stake in shares of HCA Healthcare during the second quarter worth $40,000. Compound Global Advisors LLC purchased a new position in HCA Healthcare in the third quarter valued at about $44,000. Finally, True Wealth Design LLC lifted its holdings in shares of HCA Healthcare by 179.5% during the 3rd quarter. True Wealth Design LLC now owns 109 shares of the company’s stock valued at $47,000 after buying an additional 70 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Buying and Selling

In other HCA Healthcare news, SVP Christopher F. Wyatt sold 4,000 shares of the company’s stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $505.00, for a total value of $2,020,000.00. Following the sale, the senior vice president directly owned 44,379 shares in the company, valued at $22,411,395. This represents a 8.27% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Michael S. Cuffe sold 1,500 shares of the business’s stock in a transaction on Tuesday, February 3rd. The shares were sold at an average price of $498.09, for a total transaction of $747,135.00. Following the completion of the sale, the executive vice president owned 30,003 shares in the company, valued at $14,944,194.27. This represents a 4.76% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 15,214 shares of company stock worth $7,797,595 in the last quarter. Corporate insiders own 1.30% of the company’s stock.

Analyst Ratings Changes

A number of analysts have issued reports on the stock. Wall Street Zen cut shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, February 14th. Jefferies Financial Group upped their price objective on shares of HCA Healthcare from $535.00 to $590.00 and gave the stock a “buy” rating in a report on Wednesday, January 28th. Wells Fargo & Company boosted their price target on HCA Healthcare from $452.00 to $481.00 and gave the stock an “equal weight” rating in a research report on Friday, January 30th. Mizuho set a $540.00 price objective on HCA Healthcare in a research note on Monday, February 2nd. Finally, Oppenheimer increased their price target on HCA Healthcare from $500.00 to $540.00 and gave the company an “outperform” rating in a report on Wednesday, January 28th. Sixteen analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $523.27.

HCA Healthcare Stock Performance

NYSE:HCA opened at $527.86 on Friday. HCA Healthcare, Inc. has a 52-week low of $295.00 and a 52-week high of $552.90. The company has a market cap of $118.04 billion, a price-to-earnings ratio of 18.60, a PEG ratio of 1.64 and a beta of 1.36. The firm’s 50-day moving average is $487.04 and its 200-day moving average is $453.28.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, topping analysts’ consensus estimates of $7.37 by $0.64. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The company had revenue of $19.51 billion during the quarter, compared to the consensus estimate of $19.67 billion. During the same quarter last year, the company earned $6.22 EPS. The company’s quarterly revenue was up 6.7% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be paid a $0.78 dividend. The ex-dividend date is Tuesday, March 17th. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.72. HCA Healthcare’s dividend payout ratio is currently 10.15%.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.